Randomized and double-blind controlled clinical trial of extracorporeal cardiac shock wave therapy for coronary heart disease

Heart and Vessels

Volumn 28, Issue 3, 2013, Pages 284-291

  Yang, Ping ^a   Guo, Tao ^b   Wang, Wei ^a   Peng, Yun Zhu ^b   Wang, Yu ^b   Zhou, Ping ^c   Luo, Zhi Ling ^b   Cai, Hong Yan ^b   Zhao, Ling ^b   Yang, Hong Wen ^c  

^a First People's Hospital of Kunming   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c KUNMING GENERAL HOSPITAL   (China)

Author keywords

Angiogenesis; Cardiac shock wave therapy; Coronary heart disease; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATINE KINASE; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; ANGIOGENESIS; ARTICLE; CELL SURVIVAL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; EXTRACORPOREAL LITHOTRIPSY; FEASIBILITY STUDY; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HEART VENTRICLE TACHYCARDIA; HOSPITAL READMISSION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOKALEMIA; ISCHEMIC HEART DISEASE; MALE; MORTALITY; MYOCARDIAL PERFUSION IMAGING; PATIENT SAFETY; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SINUS ARREST; THORAX PAIN; TWO DIMENSIONAL ECHOCARDIOGRAPHY; WALKING;

AGED; CHI-SQUARE DISTRIBUTION; CHINA; CORONARY DISEASE; DOUBLE-BLIND METHOD; FEMALE; FLUORODEOXYGLUCOSE F18; HIGH-ENERGY SHOCK WAVES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 84878685905     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-012-0244-7     Document Type: Article

References (23)

1. Iwasaki K, Matsumoto T, Aono H, Furukawa H, Nagamachi K, Samukawa M (2010) Distribution of coronary atherosclerosis in patients with coronary artery disease. Heart Vessels 25:14-18
2. Kayrak M, Bacaksiz A, Ulgen MS, Vatankulu MA, Zengin K, Ayhan SS, Basaral MK, Büyükbas S, Kiyici A (2011) Plasma concentrations of soluble CD40 ligand in smokers with acute myocardial infarction: a pilot study. Heart Vessels 26:131-137
3. Ichioka S, Shibata M, Kosaki K, Sato Y, Harii K, Kamiya A (1997) Effects of shear stress on wound healing angiogenesis in the rabbit ear chamber. J Surg Res 72:29-35
4. Fisher AB, Chien S, Barakat AI, Nerem RM (2001) Endothelial cellular response to altered shear stress. Am J Physiol Lung Cell Mol Physiol 281:L529-L533
5. Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, Abe K, Matsumoto Y, Kajihara N, Eto M, Matsuda T, Yasui H, Takeshita A, Sunaqawa K (2004) Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia induced myocardial dysfunction in pigs in vivo. Circulation 110:3055-3061
6. Gutersohn A, Gaspari G (2000) Shock waves upregulate vascular endothelial growth factor m-RNA in human umbilical vascular endothelial cells. Circulation 102(suppl):1-18
7. Fukumoto Y, Ito A, Uwatoku T, Matoba T, Kishi T, Tanaka H, Takeshita A, Sunaqawa K, Shimokawa H (2006) Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease. Coron Artery Dis 17:63-70
8. Khattab AA, Brodersen B, Schuermann-Kuchenbrandt D, Beurich H, Tölg R, Geist V, Schäfer T, Richardt G (2007) Extracorporeal cardiac shock wave therapy: first experience in the everyday practice for treatment of chronic refractory angina pectoris. Int J Cardiol 121:84-85
9. Ito K, Fukumoto Y, Shimokawa H (2009) Extracorporeal shock wave therapy as a new and non-invasive angiogenic therapy. Tohoku J Exp Med 219:1-9
10. Wang Y, Guo T, Cai HY, Ma TK, Tao SM, Sun S, Chen MQ, Gu Y, Pang JH, Xiao JM, Yang XY, Yang C (2010) Cardiac shock wave therapy reduces angina and improves myocardial function in patients with refractory coronary artery disease. Clin Cardiol 33:693-699
11. Vasyuk YA, Hadzegova AB, Shkolnik EL, Kopeleva MV, Krikunova OV, Iouchtchouk EN, Aronova EM, Ivanova SV (2010) Initial clinical experience with extracorporeal shock wave therapy in treatment of ischemic heart failure. Congest Heart Fail 16:226-230
12. Mariotto S, Cavalieri E, Amelio E, Ciampa AR, de Prati AC, Marlinghaus E, Russo S, Suzuki H (2005) Extracorporeal shock waves: from lithotripsy to anti-inflammatory action by NO production. Nitric Oxide 12:89-96
13. Ciampa AR, de Prati AC, Amelio E, Cavalieri E, Persichini T, Colasanti M, Musci G, Marlinghaus E, Suzuki S, Mariotto S (2005) Nitric oxide mediates anti-inflammatory action of extracorporeal shock waves. FEBS Lett 579:6839-6845
14. Oi K, Fukumoto Y, Ito K, Uwatoku T, Abe K, Hizume T, Shimokawa H (2008) Extracorporeal shock wave therapy ameliorates hindlimb ischemia in rabbits. Tohoku J Exp Med 214:151-158
15. Uwatoku T, Ito K, Abe K, Oi K, Hizume T, Sunagawa K, Shimokawa H (2007) Extracorporeal cardiac shock wave therapy proves left ventricular remodeling after acute myocardial infarction in pigs. Coron Artery Dis 18:397-404
16. Kikuchi Y, Ito K, Ito Y, Shiroto T, Tsuburaya R, Aizawa K, Hao K, Fukumoto Y, Takahashi J, Takeda M, Nakayama M, Yasuda S, Kuriyama S, Tsuji I, Shimokawa H (2010) Double-blind and placebo-controlled study of the effectiveness and safety of extracorporeal cardiac shock wave therapy for severe angina pectoris. Circ J 74:589-591
17. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS (2002) American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the cardiac imaging committee of the Council on Clinical Cardiology of the American Heart Association. J Nucl Cardiol 9:240-245
18. Fang LG, Li J, Chen LB, Li F, Chen W, Fang Q (2009) Comparison of low-dose adenosine echocardiography and dual-isotope emission simultaneous acquisition for assessment of myocardial viability in early acute myocardial infarction. J Clin Cardiol (China) 25:623-626
19. Wang Y, Guo T, Cai HY, Ma TK, Tao SM, Chen MQ, Gu Y, Pan JH, Xiao JM, Zhao L, Yang XY, Yang C (2010) Extracorporeal cardiac shock wave therapy for treatment of coronary artery disease. Chin J Cardiol 38:711-715
20. Cai HY, Wang Y, Li L, Zhao L, Xiao JM, Cao JM, Yang XY, Yang C, Guo T (2010) Changes in the number of endothelial progenitor cells from peripheral blood in patients with coronary atherosclerotic heart disease before and after extracorporeal cardiac shock wave therapy. J Clin Rehabil Tissue Eng Res (China) 14:9249-9252
21. Tao SM, Gao T, Wang Y, Cai HY, Yang C (2011) Extracorporeal cardiac shock wave therapy improved myocardial micro-vascular circulation after acute myocardial infarction at early stage in pigs. J Sichuan Univ (Med Sci Edi) 42:222-226
22. 99mTc- sestamibi to assess myocardial viability and function in a single study. Eur J Nucl Med Mol Imaging 32:195-202
23. 18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction. Eur J Nucl Med Mol Imaging 32:972-979